Role of tranexamic acid in controlling bleeding in spine surgeries.
Not Applicable
- Conditions
- Health Condition 1: M96-M96- Intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified
- Registration Number
- CTRI/2021/06/034209
- Lead Sponsor
- Kasturba medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All open spine surgeries.
2. Patients with age 18 years and greater.
3. Patients with low risk of anaesthesia related complications( i.e. ASA I and ASA II patients ).
will be enrolled for the study.
Exclusion Criteria
1.Minimally invasive spine surgeries and unilateral single level fenestration discectomies.
2.Patients with age less than 18 years.
3.Patients with blood dyscrasias ,coagulation profile abnormality and renal disorders.
4.Patients with high risk of anaesthesia related complications ASA III and ASA IV patients.
5.Duration of surgery more than 6 hours.
6.Patients on medication which can interfere with tranexamic acid such as aspirin ,clopidogrel , dabigatran , heparin , enoxaparin , fondaparinux.
will be excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method